Envíos recientes

The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach

Munkhammar, Åsa A.; Åsten, Pamela; Bouzariouh, Anouar; van Roey, Victor; Ombashi, Saranda; Mathijssen, Irene; MUNILL-FERRER, MONTSERRAT (Wolters Kluwer Health, 2025-11)

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

Moore, Kathleen; FABBRO, MICHEL; OMalley, David; Grisham, Rachel; Monk, Bradley; Van Nieuwenhuysen, Els (Elsevier, 2025-11)

Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add study

Caballero, Fernando ; Francisco J., Campos-Lucas; AGUILAR AMAT PRIOR, MARIA JOSE; García Martínez, Alberto; Toledo, Manuel; SERRANO-CASTRO, PEDRO J; Campos-Fernandez, Daniel; Gifreu Fraixinó, Ariadna (Wiley, 2025-10)

Desarrollo de la aplicación móvil Guía de conciliación de la medicación en el paciente crítico

Ruiz-Ramos, Jesús; de Lorenzo Pinto, Ana; MARTIN CEREZUELA, MARIA; Becerril Moreno, Fernando; Domingo-Chiva, Esther; Valera-Rubio, Marta; Doménech-Moral, Laura (Elsevier, 2025-11)

The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation

Louca, Panayiotis; Lin, Yu; Kouraki, Afroditi; Estévez Vázquez, Olga; Martínez Gómez, María; Serra Cusidó, Maria; Pericas, Juan M (Elsevier, 2025-11)

Scientia. Depósito de Información Digital del Departamento de Salud

Institut Català de la Salut - ICS: Envíos recientes

The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add study

Desarrollo de la aplicación móvil Guía de conciliación de la medicación en el paciente crítico

The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation

Scientia. Depósito de Información Digital del Departamento de Salud

Institut Català de la Salut - ICS: Envíos recientes

The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach ﻿

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer ﻿

Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add study ﻿

Desarrollo de la aplicación móvil Guía de conciliación de la medicación en el paciente crítico ﻿

The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation ﻿

The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add study

Desarrollo de la aplicación móvil Guía de conciliación de la medicación en el paciente crítico

The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation